APR 13, 2020 8:33 AM PDT

Computer Model Predicts How Drugs Affect Heart Rhythm

WRITTEN BY: Annie Lennon

Cardiotoxicity, heart electrophysiology dysfunction or muscle damage,  is one of the most common reasons why drugs are withdrawn from the market. Now, researchers have created a computer model capable of screening drugs for unintended cardiac side effects including arrhythmia, also known as an irregular heart beat. 

Until now, there has been no clear way to determine whether drugs will have therapeutic or harmful effects on hERG-encoded potassium channels necessary for normal heart rhythm. Co-leader of the study creating the predictive computer model, Colleen E. Clancy, professor of physiology and membrane biology at the University of California says, “One main reason for a drug being removed from the market is potentially life-threatening arrhythmias...Even drugs developed to treat arrhythmia have ended up actually causing them.”

To resolve this issue, Clancy and her team developed a computer model capable of determining a drug’s chemical structure and then predicting its impact on measures of cardiotoxicity including heart rhythm. Using a drug’s chemical formula, they are able to map how a drug interacts with the hERG channels alongside cells and tissue in the heart. They then validate the outcomes with comparisons to clinical data from electrocardiogram (ECG) results from patients. 

For a study investigating its efficacy, the researchers validated their model by investigating two drugs known to interact with hERG channels- one known to have a safe drug profile, and the other known to increase the risk of arrhythmia. Comparing their mapped models to existing ECG results on the drugs, they found their system to be accurate in predicting rates of cardiotoxicity including arrhythmia. 

Clancy now hopes that the model may be useful as a pre-market test for cardiac drug safety and drug discovery. She also hopes that the model will eventually be used to assess drug safety for other organs too, including the liver and the brain. Clancy says, “Every new drug needs to go through a screening for cardiac toxicity, and this could be an important first step to suggesting harm or safety before moving on to more expensive and extensive testing.”



Sources: Circulation Research, SIFY

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
FEB 26, 2020
Cardiology
FEB 26, 2020
Why is heart disease the world's leading cause of death?
Heart diseases, also known as cardiovascular diseases (CVDs) are the number 1 cause of death around the world. In 2016 a ...
MAR 01, 2020
Cardiology
MAR 01, 2020
Vegetarian Diet May Reduce Stroke Risk
Stroke is the world’s second leading cause of death. Now, researchers from Tzu Chi University in Hualien, Taiwan h ...
MAR 06, 2020
Cardiology
MAR 06, 2020
Why Is Good Nutrition Advise So Hard to Come By
Nutrition advice seems to come from everywhere. Exposure to this advice, one is likely to find endless examples of confl ...
APR 09, 2020
Health & Medicine
APR 09, 2020
Middle-Aged Women Have Time to Reduce Stroke Risk
According to the American Heart Association (AHA), women are generally more likely than men to have a stroke, die from s ...
APR 21, 2020
Cardiology
APR 21, 2020
Why are More Young People Having Heart Attacks?
Fewer and fewer people have heart attacks in the US thanks to improved lifestyle factors, such as a general reduction in ...
MAY 15, 2020
Technology
MAY 15, 2020
What is HARVEY?
One of the biggest challenges facing clinical workers is trying to explore user interface treatment options easily witho ...
Loading Comments...